4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      High Incidence of Cranial Synostosis and Chiari I Malformation in Children With X‐Linked Hypophosphatemic Rickets (XLHR)

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          ABSTRACT

          X‐linked hypophosphatemic rickets (XLHR) represents the most common form of genetic hypophosphatemia and causes rickets and osteomalacia in children because of increased FGF23 secretion and renal phosphate wasting. Even though cranial vault and craniovertebral anomalies of potential neurosurgical interest, namely early closure of the cranial sutures and Chiari type I malformation, have been observed in children with XLHR, their actual incidence and characteristics are not established. The aims of this study were to analyze the incidence of cranial and cervico‐occipital junction (COJ) anomalies in children with XLHR and describe its features. This is a retrospective study of CT scans of the head and skull in 44 XLHR children followed at the French Reference Center for Rare Diseases of the Calcium and Phosphate Metabolism. Forty‐four children with XLHR, 15 boys and 29 girls, aged 8.7 ± 3.9 years at time of CT scan, were studied. We found that 59% of XLHR children had a complete or partial fusion of the sagittal suture and 25% of XLHR children showed protrusion of the cerebellar tonsils. A history of dental abscesses was associated with craniosynostosis, and craniosynostosis was associated with abnormal descent of cerebellar tonsils. Only 2 patients showed neurologic symptoms. Four of 44 patients (9%) required neurosurgery. This study highlights that sagittal suture fusion and Chiari type I malformation are frequent complications of XLHR. The incidence of sagittal synostosis in XLHR is actually extremely high and was probably underestimated so far. Chiari type I malformation is also frequent. Because diagnosis of craniovertebral anomalies can be underestimated on a purely clinical basis, radiological studies should be considered in XLHR children if a proper diagnosis is warranted. © 2018 The Authors. Journal of Bone and Mineral Research Published by Wiley Periodicals, Inc.

          Related collections

          Most cited references29

          • Record: found
          • Abstract: found
          • Article: not found

          Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia.

          Tumor-induced osteomalacia (TIO) is one of the paraneoplastic diseases characterized by hypophosphatemia caused by renal phosphate wasting. Because removal of responsible tumors normalizes phosphate metabolism, an unidentified humoral phosphaturic factor is believed to be responsible for this syndrome. To identify the causative factor of TIO, we obtained cDNA clones that were abundantly expressed only in a tumor causing TIO and constructed tumor-specific cDNA contigs. Based on the sequence of one major contig, we cloned 2,270-bp cDNA, which turned out to encode fibroblast growth factor 23 (FGF23). Administration of recombinant FGF23 decreased serum phosphate in mice within 12 h. When Chinese hamster ovary cells stably expressing FGF23 were s.c. implanted into nude mice, hypophosphatemia with increased renal phosphate clearance was observed. In addition, a high level of serum alkaline phosphatase, low 1,25-dihydroxyvitamin D, deformity of bone, and impairment of body weight gain became evident. Histological examination showed marked increase of osteoid and widening of growth plate. Thus, continuous production of FGF23 reproduced clinical, biochemical, and histological features of TIO in vivo. Analyses for recombinant FGF23 products produced by Chinese hamster ovary cells indicated proteolytic cleavage of FGF23 at the RXXR motif. Recent genetic study indicates that missense mutations in this RXXR motif of FGF23 are responsible for autosomal dominant hypophosphatemic rickets, another hypophosphatemic disease with similar features to TIO. We conclude that overproduction of FGF23 causes TIO, whereas mutations in the FGF23 gene result in autosomal dominant hypophosphatemic rickets possibly by preventing proteolytic cleavage and enhancing biological activity of FGF23.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis.

            We analyzed the effects of an FGF-23 injection in vivo. FGF-23 caused a reduction in serum 1,25-dihydroxyvitamin D by altering the expressions of key enzymes for the vitamin D metabolism followed by hypophosphatemia. This study indicates that FGF-23 is a potent regulator of the vitamin D and phosphate metabolism. The pathophysiological contribution of FGF-23 in hypophosphatemic diseases was supported by animal studies in which the long-term administration of recombinant fibroblast growth factor-23 reproduced hypophosphatemic rickets with a low serum 1,25-dihydroxyvitamin D [1,25(OH)2D] level. However, there is no clear understanding of how FGF-23 causes these changes. To elucidate the molecular mechanisms of the FGF-23 function, we investigated the short-term effects of a single administration of recombinant FGF-23 in normal and parathyroidectmized animals. An injection of recombinant FGF-23 caused a reduction in serum phosphate and 1,25(OH)2D levels. A decrease in serum phosphate was first observed 9 h after the injection and was accompanied with a reduction in renal mRNA and protein levels for the type IIa sodium-phosphate cotransporter (NaPi-2a). There was no increase in the parathyroid hormone (PTH) level throughout the experiment, and hypophosphatemia was reproduced by FGF-23 in parathyroidectomized rats. Before this hypophosphatemic effect, the serum 1,25(OH)2D level had already descended at 3 h and reached the nadir 9 h after the administration. FGF-23 reduced renal mRNA for 25-hydroxyvitamin D-1alpha-hydroxylase and increased that for 25-hydroxyvitamin D-24-hydroxylase starting at 1 h. In addition, an injection of calcitriol into normal mice increased the serum FGF-23 level within 4 h. FGF-23 regulates NaPi-2a independently of PTH and the serum 1,25(OH)2D level by controlling renal expressions of key enzymes of the vitamin D metabolism. In conclusion, FGF-23 is a potent regulator of phosphate and vitamin D homeostasis.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP Consortium.

              X-linked hypophosphatemic rickets (HYP) is a dominant disorder characterised by impaired phosphate uptake in the kidney, which is likely to be caused by abnormal regulation of sodium phosphate cotransport in the proximal tubules. By positional cloning, we have isolated a candidate gene from the HYP region in Xp22.1. This gene exhibits homology to a family of endopeptidase genes, members of which are involved in the degradation or activation of a variety of peptide hormones. This gene (which we have called PEX) is composed of multiple exons which span at least five cosmids. Intragenic non-overlapping deletions from four different families and three mutations (two splice sites and one frameshift) have been detected in HYP patients, which suggest that the PEX gene is involved in the HYP disorder.
                Bookmark

                Author and article information

                Contributors
                Federico.dirocco@chu-lyon.fr
                Journal
                J Bone Miner Res
                J Bone Miner Res
                10.1002/(ISSN)1523-4681
                JBMR
                Journal of Bone and Mineral Research
                John Wiley and Sons Inc. (Hoboken )
                0884-0431
                1523-4681
                20 November 2018
                March 2019
                : 34
                : 3 ( doiID: 10.1002/jbmr.v34.3 )
                : 490-496
                Affiliations
                [ 1 ] APHP, Reference Center for Rare Disorders of the Calcium and Phosphate Metabolism Filière OSCAR Bicêtre Paris Sud Hospital Le Kremlin Bicêtre France
                [ 2 ] APHP, Endocrinology and Diabetes for Children Bicêtre Paris Sud Hospital Le Kremlin Bicêtre France
                [ 3 ] Plateforme d'Expertise Maladies Rares Paris‐Sud Bicêtre Paris Sud Hospital Le Kremlin Bicêtre France
                [ 4 ] APHP, Department of Pediatric Radiology Bicêtre Paris Sud Hospital Le Kremlin Bicêtre France
                [ 5 ] Pediatric Nephrology Hôpital Femme Mère Enfant Hospices Civiles de Lyon and University Claude Bernard Lyon 1 Bron Cedex France
                [ 6 ] EA 2496 Pathologies, Imaging, and Biotherapies of the Tooth Dental School Université Paris Descartes Sorbonne; APHP Odontology Department, Groupement Hospitalier Nord Val de Seine (Bretonneau) Paris France
                [ 7 ] INSERM U1185 and Paris Sud Paris‐Saclay University Bicêtre Paris Sud Hospital Le Kremlin Bicêtre France
                [ 8 ] Pediatric Neurosurgery, Hôpital Femme Mère Enfant Hospices Civiles de Lyon and University Claude Bernard Lyon 1 Bron Cedex France
                [ 9 ] Reference Center for Craniosynostosis INSERM 1033 Lyon France
                Author notes
                [*] [* ] Address correspondence to: Federico Di Rocco, MD, PhD, Pediatric Neurosurgery, Hôpital Femme Mère Enfant, Hospices Civiles de Lyon and University Claude Bernard Lyon 1, Bron Cedex, France. E‐mail: Federico.dirocco@ 123456chu-lyon.fr

                Article
                JBMR3614
                10.1002/jbmr.3614
                7816089
                30352126
                c5c1fd3f-d916-4dbf-ac29-6c7585729655
                © 2018 The Authors. Journal of Bone and Mineral Research Published by Wiley Periodicals, Inc.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 07 August 2018
                : 29 September 2018
                : 06 October 2018
                Page count
                Figures: 2, Tables: 4, Pages: 7, Words: 4274
                Funding
                Funded by: Plateforme d'Expertise Maladies Rares Paris‐Sud
                Categories
                Original Article
                Original Articles
                Custom metadata
                2.0
                March 2019
                Converter:WILEY_ML3GV2_TO_JATSPMC version:5.9.6 mode:remove_FC converted:20.01.2021

                Human biology
                x‐linked hypophosphatemic rickets (xlhr),chiari type i malformation,scaphocephaly,craniosynostosis

                Comments

                Comment on this article